Fast Five Quiz: Do You Know the Risk Factors, Diagnostic Tests, and Treatment for Pancreatic Cancer?

Mary Denshaw-Burke, MD

Disclosures

October 14, 2014

Pancreatic carcinoma is unfortunately usually a fatal disease. The collective median survival time for all patients is 4-6 months. The relative 1-year survival rate for patients with pancreatic cancer is only 24%, and the overall 5-year survival rate is 5%. However, patients with neuroendocrine and cystic neoplasms of the pancreas, such as mucinous cystadenocarcinomas or intraductal papillary mucinous neoplasms, have much better survival rates than do patients with pancreatic adenocarcinoma.

For more on the prognosis in pancreatic cancer, read here.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....